← Open Payments lookup

MONICA LOVINS: Open Payments

NPI 1861732331 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$7,098 in 134 payments from 19 companies in 2025. Trend: 2023 $2,780 · 2024 $2,969 · 2025 $7,098

Food & beverage: $3,357Consulting: $2,640Travel & lodging: $1,041Education: $60
CompanyPaymentsAmount
Gilead Sciences, Inc.28$4,447
ABBVIE INC.26$545
Madrigal Pharmaceuticals10$385
PFIZER INC.11$256
Janssen Biotech, Inc.11$231
Ardelyx, Inc.10$205
GENZYME CORPORATION3$162
Novo Nordisk Inc2$141
Takeda Pharmaceuticals U.S.A., Inc.5$124
Actelion Pharmaceuticals US, Inc.1$120

Products named: Livdelzi, REZDIFFRA, SKYRIZI, TREMFYA, DUPIXENT, IBSRELA, VELSIPITY, CREON.

Industry payments across MD — which companies pay providers there.